Researchers took chemotherapy in the first week and the fourth week after radiotherapy, with 5-fluorouracil 500 mg/m 2 , calcium leucovorin 200 mg, d1-5 with intravenous drip, Oxaliplatin 130 mg/m 2 and d1 with intravenous drip 2 h, 21 days was one cycle. Kaplan-Meier ...
Another thought the neurologist has is But thats treated with chemotherapy. There is no way Kath can tolerate that either and she is no longer responding to the systemic treatment. We talked about what Kath would want done when things came to this stage. Its not like we worked out a large...
The chemotherapy was administered every two weeks until the patients declined further doses or until disease pro- gression or limiting toxicities. Before each cycle of administration, a physical examin- ation and laboratory tests were performed, in order to evaluate the ECOG PS status of the ...
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27-40. doi:10.1016/S0140-6736(21)00797-2PubMedGoogle Scholar...
chemotherapy cycle. For tumor evaluation, CT or MRI was carried out according to the Revised Response Evaluation Criteria in Solid Tumors (mRECIST)25at baseline, 3 ± 1 weeks after the last chemotherapy cycle, and once every 2 ± 1 months during follow-up. If the patients suffered ...
ChineseJournalofMedicinalGuide2014Volume16No.3(SerialNo.125)456结肠癌一旦确诊,20%～30%已属晚期,丧失手术机会,预期寿命仅为8个月,远处转移是结肠癌患者主要的死亡原因,约30%结肠癌根治术后死于肿瘤复发[1,2]。常用的一线治疗方案是FOLFOX方案和FOLFIRI方案[3]。2个方案在有效率和生存期方面无差别,因此NCCN指南...
[A case of advanced colon cancer with peritoneal dissemination effectively treated with modified FOLFOX6 chemotherapy]. A 50-year-old woman was diagnosed with ascending with bilateral , , and . Nine courses of mFOLFOX6 treatment resulted in the disappearance of her ascites a... K Tanaka,K Hira...
Polymorphisms contribute to inter-individual differences and show a promising predictive role for chemotherapy-related toxicity in colon cancer (CC). TOSCA is a multicentre, randomized, non-inferiority, phase III study conducted in high-risk stage II/sta
Patients not completing the first cycle for reasons other than DLTs were considered not evaluable and replaced. The chemotherapy backbone (mFOLFOX6 or FOLFIRI) was chosen at the investigators’ discretion. The chemotherapy regimens were as follows: mFOLOX6 comprised oxaliplatin 85 mg/m2 on day ...
To explore the clinical efficacy and toxic and side effects of recombinant human endostatin (rh- endostatin/endostar) combined with chemotherapy in the tre... SR Gao,LM Li,HP Xia,... - 《Asian Pacific Journal of Cancer Prevention Apjcp》 被引量: 19发表: 2015年 Pro-Angiogenic Mediators as ...